CME Enduring Materials

Funding provided through educational grants from pharmaceutical industry supporters.

Efficacy, Safety, and Tolerability Considerations in the Novel Treatment of Major Depressive Disorder PsychCast™

Release Date: June 2009

Termination Date: 6/30/2011

Supported by: Bristol-Myers Squibb

Release Date: May 2009

Termination Date: 5/31/2011

Supported by: Shire Pharmaceuticals Inc.

Release Date: March 2009

Termination Date: 3/31/2011

Supported by: Eli Lilly and Company

Addictive Disorders	Miscellaneous
Alcohol-Related Disorders	Mood Disorders
Anxiety Disorders	Movement Disorders
Attention-Deficit/Hyperactivity Disorder	Multiple Sclerosis
Autism Spectrum Disorders	Neurodegenerative Disorders
Bipolar Disorders	Neuropathy
Body Dysmorphic Disorder	Parkinson’s Disease
Brain Imaging	Personality Disorders
Chronic Pain	Pharmacologic Treatments
Dementia	Postpartum Depression
Depression	Psychosis
Eating Disorders	Schizophrenic Disorders
Epilepsy	Sexual Dysfunction
Fibromyalgia	Sleep Disorders
Impulse-Control Disorders	Stroke
Irritable Bowel Syndrome	Treatment Adherence
Malingering